Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer
Adult
Male
0301 basic medicine
Neutrophils
Young Adult
03 medical and health sciences
Stomach Neoplasms
Humans
Lymphocyte Count
Neutrophil-to-lymphocyte ratio
RC254-282
Aged
Aged, 80 and over
Inflammation
Platelet Count
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Middle Aged
Platelet-to-lymphocyte ratio
Prognosis
3. Good health
Survival Rate
Treatment Outcome
Preoperative Period
Original Article
Female
Gastric cancer
Follow-Up Studies
DOI:
10.1186/s40880-016-0122-2
Publication Date:
2016-06-25T19:00:52Z
AUTHORS (10)
ABSTRACT
The preoperative neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte (PLR) are associated with poor prognosis of gastric cancer. We aimed to determine whether combination NLR PLR (NLR–PLR) could better predict survival patients after curative resection for stage I–II collected data from medical records cancer undergoing between December 2000 November 2012 at Sun Yat-sen Cancer Center. NLR–PLR was calculated as follows: both elevated (≥2.1) (≥120) were given a score 2, only one or neither 1 0, respectively. Kaplan–Meier analysis log-rank tests revealed significant differences in overall (OS) among scores 2 (P < 0.001). Multivariate showed that OS independently [hazard (HR) = 1.51, 95% confidence interval (CI) 1.02–2.24, P 0.039] TNM (HR 1.36, CI 1.01–1.83, 0.041). However, other systemic inflammation-based prognostic scores, including modified Glasgow score, nutritional index, platelet count NLR, not. In stage-stratified analysis, significance maintained I 0.001) II cancers 0.022). addition, area under receiver operating characteristic curve higher than those NLR-PLR is useful predictor postoperative may help identify high-risk rational therapy timely follow-up.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (32)
CITATIONS (51)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....